$4.6 million grant will help Stratatech start clinical trials of skin substitute
Madison-based Stratatech Corp. is getting a $4.6 million grant to help fund the start of clinical trials of ExpressGraft, a skin substitute designed to heal diabetes-related foot ulcers. (WISCONSIN STATE JOURNAL, 11/1)
To access this post, you must purchase Premium Subscription - Daily Email and Full Website Access.